LIVE
Home
Politics
Business
Opinion
Technology
Lifestyle
Entertainment
Video
Biogen shares plunge nearly 30% after ending trial for potential blockbuster Alzheimer's drug
Business
March 21, 2019
This article is being updated.
Previous article: Boeing confirms changes to the 737 Max's software and training
Prev
Next article: Biogen heads for the worst day in a decade after ending trial for blockbuster Alzheimer's drug
Next
via
CNBC
March 21st 2019
MixedTimes.com
Business
Biogen shares plunge nearly 30% after ending trial for potential blockbuster Alzheimer's drug
Home
Politics
Business
Opinion
Technology
Lifestyle
Entertainment
Video